New in vitro LIQUID BIOPSY technology using disposable microfluidics (patented technology) for detection, imaging, sorting and storage of single circulating tumor cells (CTC) based on their abnormal metabolism. CTC are delivered in native conditions for further analysis (e.g.: DNA) or biobanking. Our solution boosts cancer research and drug development, aiming to drive key decisions on cancer treatment.